• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Buyouts

PAI acquires stake in Labeyrie

  • Ellie Pullen
  • 16 June 2014
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

PAI partners has acquired a stake in Labeyrie Fine Foods from LBO France, with the aim of becoming an equal shareholder in the business alongside French food cooperative Lur Berri.

The transaction is valued in the region of €500m, according to French daily Les Echos – equivalent to 8.2x EBITDA.

Following the transaction, the capital structure of Labeyrie is expected to eventually comprise equal stakes held by PAI and Lur Berri with the remainder being held by management.

Labeyrie Fine Foods

  • DEAL:

    SBO

  • VALUE:

    n/d (€500m est)

  • LOCATION:

    Came

  • SECTOR:

    Food products

  • FOUNDED:

    1946

  • TURNOVER:

    €757m

  • EBITDA:

    €72m

  • STAFF:

    4,100

  • VENDOR:

    LBO France

LBO France is believed to be selling its entire 33% stake. Lur Berri is currently the majority shareholder in Labeyrie, with a stake of around 62.9%.

LBO France acquired the business in January 2012, buying a 33% stake via its White Knight VIII fund in a deal that reportedly valued the business at around €600m.

The holding was previously named Alfesca and was owned by Icelandic investor Kjalar Invest, Icelandic bank Kaupthing and Lur Berri, the latter of which held a 49.8% stake. Lur Berri subsequently increased its shareholding in Labeyrie when LBO France entered the company's capital structure.

In March this year, Labeyrie issued €275m of senior secured notes to refinance its existing facilities. LBO France partially realised its investment through the refinancing, as part of the proceeds were earmarked towards repaying subordinated shareholder convertible bonds (€59.5m overall, leaving roughly €21m outstanding).

Company
Founded in 1946 and headquartered in Came, Labeyrie is a producer of luxury food products such as smoked salmon, foie gras and blinis. The company operates 15 production sites, 13 of which are located in France.

Labeyrie's main markets are France and the UK, though it also distributes to the Benelux region, Switzerland, Italy and 40 other countries. The company employs 4,100 staff and generated turnover of €757m in 2013, as well as an EBITDA of €72m.

At the time of LBO France's acquisition, Labeyrie generated €700m in turnover and a €58m EBITDA.

People
Xavier Govare is the CEO of Labeyrie; Olivier Gemin is the CEO of Lur Berri. Frédéric Stévenin is a partner at PAI, responsible for the firm's investments in the food and consumer goods sector.

Advisers
Vendor - Mayer Brown,
Xavier Jaspar, Emily Pennec (Legal). 

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Buyouts
  • France
  • Consumer
  • France
  • PAI Partners
  • LBO France
  • Secondary buyout

More on Buyouts

Clinical trials and biotechnology
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • Buyouts
  • 04 September 2023
EMEA Public to Private M&A
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • Investments
  • 04 September 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023
Ice cream
Exponent divests ‘significant' stake in Meadow to Canadian investor

Since 2018, GP has diversified food ingredients company's focus beyond commodity dairy

  • Exits
  • 22 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013